Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin Patch for Peripheral Neuropathic Pain
NCT02228928Phase 2Completed
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Start
- Feb 2009
- Primary completion
- May 2011
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capsaicin 8% patch in postherpetic neuralgia (PHN), diabetic peripheral neuropathy (DPN), sponsored by Samyang Biopharmaceuticals Corporation. Started Feb 2009; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
postherpetic neuralgia (PHN)diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT02228928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02228928.